KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Goodwill: 2016-2024

Historic Goodwill for Amneal Pharmaceuticals (AMRX) over the last 9 years, with Dec 2024 value amounting to $597.4 million.

  • Amneal Pharmaceuticals' Goodwill fell 0.40% to $595.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $595.9 million, marking a year-over-year decrease of 0.40%. This contributed to the annual value of $597.4 million for FY2024, which is 0.20% down from last year.
  • Amneal Pharmaceuticals' Goodwill amounted to $597.4 million in FY2024, which was down 0.20% from $598.6 million recorded in FY2023.
  • In the past 5 years, Amneal Pharmaceuticals' Goodwill registered a high of $598.9 million during FY2022, and its lowest value of $522.8 million during FY2020.
  • In the last 3 years, Amneal Pharmaceuticals' Goodwill had a median value of $598.6 million in 2023 and averaged $598.3 million.
  • Per our database at Business Quant, Amneal Pharmaceuticals' Goodwill rose by 24.63% in 2020 and then fell by 0.20% in 2024.
  • Amneal Pharmaceuticals' Goodwill (Yearly) stood at $522.8 million in 2020, then climbed by 13.43% to $593.0 million in 2021, then rose by 0.98% to $598.9 million in 2022, then fell by 0.04% to $598.6 million in 2023, then dropped by 0.20% to $597.4 million in 2024.